MA49837A - Compositions pharmaceutiques - Google Patents
Compositions pharmaceutiquesInfo
- Publication number
- MA49837A MA49837A MA049837A MA49837A MA49837A MA 49837 A MA49837 A MA 49837A MA 049837 A MA049837 A MA 049837A MA 49837 A MA49837 A MA 49837A MA 49837 A MA49837 A MA 49837A
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762544346P | 2017-08-11 | 2017-08-11 | |
| GBGB1713660.7A GB201713660D0 (en) | 2017-08-25 | 2017-08-25 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49837A true MA49837A (fr) | 2020-06-17 |
Family
ID=60037096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049837A MA49837A (fr) | 2017-08-11 | 2018-08-13 | Compositions pharmaceutiques |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200261383A1 (enExample) |
| EP (1) | EP3664780A1 (enExample) |
| JP (1) | JP2020530475A (enExample) |
| KR (1) | KR20200038987A (enExample) |
| CN (1) | CN111032018A (enExample) |
| AU (1) | AU2018315034A1 (enExample) |
| BR (1) | BR112020002325A2 (enExample) |
| CA (1) | CA3071772A1 (enExample) |
| GB (1) | GB201713660D0 (enExample) |
| MA (1) | MA49837A (enExample) |
| SG (1) | SG11202001179YA (enExample) |
| TW (1) | TW201919600A (enExample) |
| WO (1) | WO2019030540A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
| GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
| WO2021028645A1 (en) | 2019-08-09 | 2021-02-18 | Kalvista Pharmaceuticals Limited | Plasma kallikrein inhibitors |
| GB201918994D0 (en) | 2019-12-20 | 2020-02-05 | Kalvista Pharmaceuticals Ltd | Treatments of diabetic macular edema and impaired visual acuity |
| GB2591730A (en) * | 2019-12-09 | 2021-08-11 | Kalvista Pharmaceuticals Ltd | New polymorphs |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070258976A1 (en) * | 2006-05-04 | 2007-11-08 | Ward Keith W | Combination Therapy for Diseases Involving Angiogenesis |
| GB2494851A (en) * | 2011-07-07 | 2013-03-27 | Kalvista Pharmaceuticals Ltd | Plasma kallikrein inhibitors |
| CA2866232A1 (en) * | 2012-05-25 | 2013-11-28 | Novartis Ag | Aqueous pharmaceutical composition containing a biologic therapeutic agent and guanidine or a guanidine derivative and an injection including the composition |
| GB2510407A (en) * | 2013-02-04 | 2014-08-06 | Kalvista Pharmaceuticals Ltd | Aqueous suspensions of kallikrein inhibitors for parenteral administration |
-
2017
- 2017-08-25 GB GBGB1713660.7A patent/GB201713660D0/en not_active Ceased
-
2018
- 2018-08-13 TW TW107128107A patent/TW201919600A/zh unknown
- 2018-08-13 US US16/637,953 patent/US20200261383A1/en not_active Abandoned
- 2018-08-13 MA MA049837A patent/MA49837A/fr unknown
- 2018-08-13 SG SG11202001179YA patent/SG11202001179YA/en unknown
- 2018-08-13 CA CA3071772A patent/CA3071772A1/en active Pending
- 2018-08-13 EP EP18758700.1A patent/EP3664780A1/en not_active Withdrawn
- 2018-08-13 KR KR1020207007099A patent/KR20200038987A/ko not_active Ceased
- 2018-08-13 CN CN201880052445.0A patent/CN111032018A/zh active Pending
- 2018-08-13 WO PCT/GB2018/052292 patent/WO2019030540A1/en not_active Ceased
- 2018-08-13 JP JP2020507672A patent/JP2020530475A/ja active Pending
- 2018-08-13 AU AU2018315034A patent/AU2018315034A1/en not_active Abandoned
- 2018-08-13 BR BR112020002325-6A patent/BR112020002325A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020002325A2 (pt) | 2020-09-01 |
| CN111032018A (zh) | 2020-04-17 |
| KR20200038987A (ko) | 2020-04-14 |
| GB201713660D0 (en) | 2017-10-11 |
| EP3664780A1 (en) | 2020-06-17 |
| US20200261383A1 (en) | 2020-08-20 |
| CA3071772A1 (en) | 2019-02-14 |
| WO2019030540A1 (en) | 2019-02-14 |
| AU2018315034A1 (en) | 2020-02-27 |
| SG11202001179YA (en) | 2020-03-30 |
| TW201919600A (zh) | 2019-06-01 |
| JP2020530475A (ja) | 2020-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| MA50541A (fr) | Formulations pharmaceutiques | |
| DK3655038T3 (da) | Farmaceutisk sammensætning | |
| EP3513809A4 (en) | MEDICAL COMPOSITION | |
| DK3256138T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam | |
| EP3641771A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| MA42303A (fr) | Formulations pharmaceutiques | |
| EP3541385A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| EP3316685A4 (en) | Lyophilized Pharmaceutical Compositions | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| EP3603642A4 (en) | PHARMACEUTICAL PREPARATION | |
| EP3463345A4 (en) | PHARMACEUTICAL COMBINATIONS | |
| DK3583943T3 (da) | Farmaceutisk sammensætning | |
| EP3914234A4 (en) | Pharmaceutical compositions | |
| EP3389633A4 (en) | Pharmaceutical compositions comprising phenylaminopyrimidine derivative | |
| EP3337463A4 (en) | PHARMACEUTICAL FORMULATIONS | |
| GB201713660D0 (en) | Pharmaceutical compositions | |
| SMT202400478T1 (it) | Composizione farmaceutica | |
| EP3646863A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3302483A4 (en) | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | |
| EP3727485C0 (en) | PHARMACEUTICAL COMPOSITION | |
| DK3601277T3 (da) | Farmaceutisk formulering | |
| EP3616722A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP3441073A4 (en) | MEDICAL COMPOSITION | |
| EP3651800A4 (en) | HYPER COMPRESSED PHARMACEUTICAL FORMULATIONS |